World famous actor's foundation grants DKK 5.5 million to Danish Parkinson's research
18 October 2013
The Michael J. Fox Foundation (MJFF) donates DKK 5.5 million to two Danish research projects on Parkinson's disease by the pharmaceutical company Lundbeck.
The two research projects which have received funding from the American actor fund develop potential drugs for the serious brain disease.
"We are proud that MJFF wants to work with us on our research," says Kim Andersen, CEO of Lundbeck's Danish research department.
"The world's leading researchers are associated with MJFF and with the research funding comes a great acknowledgement of the work we do here at Lundbeck," Kim Andersen continues.
The Michael J. Fox Foundation is one of the world's leading knowledge centres on Parkinson's disease and works to find a cure for the disease and better treatment.
The fund was founded by the American actor Michael J. Fox who, just like more than five million other people worldwide, suffers from Parkinson's.
"Our foundation is designated to further the research on finding a better treatment for the millions of people living with Parkinson's disease. The two Lundbeck projects look promising in terms of being able to make a real difference in these patients' lives by reducing the symptoms and by delaying the disease," says the chief executive officer of The Michael J. Fox Foundation, Todd Sherer, PhD.
So far, the fund has donated more than DKK 1.9 billion to research on Parkinson's disease.